News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Centocor, Inc. (JNJ) Enters Into Oncology Target Licensing Agreement Wth Centocor Research And Development, Inc.


10/11/2006 11:35:35 AM

MONTREAL--(BUSINESS WIRE)--Privately held Caprion Pharmaceuticals Inc. today announced that is has entered into an agreement with Centocor Research and Development, Inc., under which Caprion will provide a number of protein targets for the development of monoclonal antibody and other potential therapeutic products for the treatment of several cancer indications.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES